Role of Biomarkers of Myocardial Injury to Predict Adverse Outcomes in Hypertrophic Cardiomyopathy.

Yu Zhang Ming-Hao LiuChanna ZhangYu-Bao ZouLianming KangLei Song

Published in: Circulation. Cardiovascular quality and outcomes (2024)

Comprehensive evaluations of biomarkers of myocardial injury, cTnI and CK-MB, have considerable value for predicting adverse outcomes among patients with HCM. Routine cTnI and CK-MB assessments may help to guide implantable cardioverter defibrillator implantation for primary prevention in HCM.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
protein kinase
clinical practice
heart failure